NEW YORK (TheStreet) -- Several small-cap stocks were moving on above-average volume during Thursday's session
Labopharm (DDSS) continued to surge, rising 8 cents, or 4.3%, to $1.96 after jumping 38.2% Wednesday. Labopharm Thursday said that its wholly owned subsidiary, Labopharm Europe Limited, has completed a distribution and supply agreement with Grunenthal GmbH for its twice-daily tramadol acetaminophen formulation for a number of European countries. Labopharm will receive 3.5 million Euros on signature and up to 4 million Euros in milestone payments upon achievement of certain regulatory and product reimbursement approvals prior to the launch of the product. Volume topped 4.2 million shares, compared to the 50-day average daily volume of 489,000, according to the Nasdaq.
Tri-Valley (TIV) shares jumped 30 cents, or 10.9%, to $3.06 as volume topped 1.1 million shares, surpassing the three-month average daily volume of 390,000. There was no company-specific news released on Tri-Valley, although investor posts on Internet message boards argued that the stock was coming up against overhead resistance and could be ready for a breakout.
Astrotech (ASTC) was on the rise, climbing 39 cents, or 19.1%, to $2.43. In late September, shares surged on strong fiscal fourth-quarter earnings and had been in a steady slope downward before Thursday's session. Volume topped 970,000 shares, compared to the 50-day average daily volume of 197,000, according to the Nasdaq. Investors on Internet message boards noted the small float of only 13 million shares, which makes the stock easy to push around. Bearish investors called the stock another pump-and-dump name for daytraders.GenCorp (GY) was on the rise with volume that was three times greater than usual after the company swung to a third-quarter profit. Shares were gaining 54 cents, or 9.7%, to $6.09 on volume that topped 1.4 million, well above the three-month average daily volume of 547,000 shares. Cell Therapeutics (CTIC) gave back some of Wednesday's 16.3% rally as the stock was down 3 cents, or 2.7%, to $1.11 during Thursday's session. Shares have been in a recent downtrend, falling more than 20% over the last month on above-average volume. Volume topped 26.8 million shares, compared to the 50-day average daily volume of 25 million, according to the Nasdaq. -- Written by Robert Holmes in New York.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV